Lilly collaborates with NIH to test Olumiant in patients hospitalized with COVID-19 Kumar Jeetendra | April 18, 2020 USA-based Eli Lilly has joined a huge and quickly developing rundown of drugmakers chipping away at treatments to battle COVID-19, with the consideration of Olumiant (baricitinib) in a National Institutes of Health (NIH)- supported preliminary. Olumiant will presently be incorporated as an arm in the Adaptive COVID-19 Treatment Trial. The investigation will test the item …
Nicoya gets NRC IRAP financing to create salivation based indicative test for COVID-19 Kumar Jeetendra | June 23, 2020 Nicoya, a main supplier of cutting edge expository instruments for the biotechnology and pharmaceutical businesses, will get warning administrations and up to $299,190 in innovative work subsidizing from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to build up a compact COVID-19 demonstrative test called Atlas. This financing comes as a …
New technology May Raise the quality of stem cells Found in regenerative medicine Kumar Jeetendra | July 8, 2020 Stem cells have been holding great promise for regenerative medicine for ages. In the last decade, many studies have revealed this form of cell, which in Spanish is called”mother cell” due to its ability to contribute to various different cell types, may be applied in regenerative medicine to diseases such as muscle and nervous system …
Drug discovery pipeline to exploit transcription factors for cancer therapy Kumar Jeetendra | July 21, 2020 Cancer is a major cause of death and among the most complicated challenges to contemporary medication. By employing cutting-edge technologies that precisely measure the effects of candidate targets and drugs on the fundamental process of transcription, the new start-up firm QUANTRO Therapeutics tries to radically change the precision and range of cell-based drug screening. QUANTRO’s …
Harbour BioMed and Viva Biotech declare key coordinated effort to promote biotech new startups Kumar Jeetendra | August 1, 2020 HBM will combine its top Harbour Mice® stage H2L2 and its expertise in global research and development of innovative molecules, with Viva Biotech’s structure-based early phase drug discovery services. This complementary partnership will provide advanced biotech startups access to next generation technologies that create synergies to accelerate the route between ideation to merchandise. The incubated …
Bruker presents Vutara™ VXL tbest-in-class super-resolution magnifying lens and spatial science investigation abilities Kumar Jeetendra | October 23, 2020 Vutara VXL serves as a biological microscopy workstation for research on DNA, RNA and proteins, from macromolecular complexes and super-structures, to chromatin structure and chromosomal substructures, to studying functional connections in genomes and in various subcellular organelles. This novel system supports innovative spatial biology research in extracellular matrix structures, extracellular vesicles (EV), virology, neuroscience, and …
CN Bio declares dispatch of medication digestion and wellbeing poisonousness testing administrations Kumar Jeetendra | October 31, 2020 Liver toxicity is a principal safety concern during drug discovery and development, with the potential to terminate expensive clinical trials already underway. The new services will incorporate the Company’s advanced Liver-on-Chip technology and experience in the field to enable researchers to create predictive and human-relevant data, improving the translatability from discovery to clinic, and hastening …
First enzyme driven biocatalytic creation of nucleic acid structure blocks Kumar Jeetendra | December 15, 2020 Researchers in TU Graz and acib succeed in the first enzyme-driven biocatalytic synthesis of lipoic acid building blocks. This facilitates the development of antiviral agents and RNA-based therapeutics. Because of this COVID 19 pandemic and the related intensive search for therapeutics and vaccines, the chemical substance class of nucleosides is undergoing an enormous increase in …
Scientists gives better comprehension of how antibiotic resistance emerges Kumar Jeetendra | January 11, 2021 Researchers at the Quadram Institute on the Norwich Research Park have shown how the development of antibiotic resistance by bacteria may have’side-effects’ for them including affecting their ability to induce disease. Antibiotic resistance is still one of the best challenges to global health with very few new antibiotics and widespread immunity. It’s been estimated that …
New fluorescence microscopy strategy produces nanoscale 3D pictures of living cells Kumar Jeetendra | January 12, 2021 A new fluorescence microscopy technique has produced the world’s first nanoscale 3D images of molecules in a whole, living cell, researchers at KTH Royal Institute of Technology reported. Ilaria Testa, an associate professor at KTH and researcher at the Science for Life Laboratory, says the technique is capable of generating images with precision that until …
Jellagen dispatches JellaGel™, the principal Collagen Type 0 Hydrogel taking available driving Extracellular Matrix Kumar Jeetendra | January 15, 2021 Jellagen® Limited, a biotechnology company manufacturing high-value Collagen Type 0 derived from jellyfish, announce the launch of their JellaGel™ Hydrogel. 3-dimensaional Hydrogels make it possible for cells to grow and interact with all of their surroundings that makes a massive difference. Cells grown in a 3D model have been shown to be more natural, with …
Bacteria responsible for seafood related stomach disturbs can go torpid and “wake up” Kumar Jeetendra | January 20, 2021 Vibrio parahaemolyticus is a marine bacterium that can lead to gastroenteritis in humans when eaten in raw or undercooked shellfish such as oysters and mussels. Some of these bacteria have the ability to turn dormant in poor growth conditions such as cold temperatures – and can stay in that state of hibernation for long periods …
